These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 21289624)

  • 1. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
    Ding Z; Wu CJ; Chu GC; Xiao Y; Ho D; Zhang J; Perry SR; Labrot ES; Wu X; Lis R; Hoshida Y; Hiller D; Hu B; Jiang S; Zheng H; Stegh AH; Scott KL; Signoretti S; Bardeesy N; Wang YA; Hill DE; Golub TR; Stampfer MJ; Wong WH; Loda M; Mucci L; Chin L; DePinho RA
    Nature; 2011 Feb; 470(7333):269-73. PubMed ID: 21289624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis.
    Qin J; Wu SP; Creighton CJ; Dai F; Xie X; Cheng CM; Frolov A; Ayala G; Lin X; Feng XH; Ittmann MM; Tsai SJ; Tsai MJ; Tsai SY
    Nature; 2013 Jan; 493(7431):236-40. PubMed ID: 23201680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating a 4-marker signature of aggressive prostate cancer using time-dependent AUC.
    Gerke TA; Martin NE; Ding Z; Nuttall EJ; Stack EC; Giovannucci E; Lis RT; Stampfer MJ; Kantoff PW; Parmigiani G; Loda M; Mucci LA
    Prostate; 2015 Dec; 75(16):1926-33. PubMed ID: 26469352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
    Sun B; Fan Y; Yang A; Liang L; Cao J
    J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing roles of TGFβ and BMP signaling in prostate cancer development.
    Lu X; Jin EJ; Cheng X; Feng S; Shang X; Deng P; Jiang S; Chang Q; Rahmy S; Chaudhary S; Lu X; Zhao R; Wang YA; DePinho RA
    Genes Dev; 2017 Dec; 31(23-24):2337-2342. PubMed ID: 29352019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Akt signaling in prostate induces a TGFβ-mediated restraint on cancer progression and metastasis.
    Bjerke GA; Yang CS; Frierson HF; Paschal BM; Wotton D
    Oncogene; 2014 Jul; 33(28):3660-7. PubMed ID: 23995785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular predicator of metastatic cancer identified.
    Printz C
    Cancer; 2011 Jul; 117(13):2829. PubMed ID: 21692044
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model.
    Zhao Y; Peng X; Baldwin H; Zhang C; Liu Z; Lu X
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166151. PubMed ID: 33892077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA2 co-opts TGFβ1/SMAD4 oncogenic signaling and inherited variants at 6q22 to modulate prostate cancer progression.
    Yang X; Zhang Q; Li S; Devarajan R; Luo B; Tan Z; Wang Z; Giannareas N; Wenta T; Ma W; Li Y; Yang Y; Manninen A; Wu S; Wei GH
    J Exp Clin Cancer Res; 2023 Aug; 42(1):198. PubMed ID: 37550764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice.
    Lu TL; Huang YF; You LR; Chao NC; Su FY; Chang JL; Chen CM
    Am J Pathol; 2013 Mar; 182(3):975-91. PubMed ID: 23313138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin.
    Qiao W; Li AG; Owens P; Xu X; Wang XJ; Deng CX
    Oncogene; 2006 Jan; 25(2):207-17. PubMed ID: 16170355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome.
    Li Y; Su J; DingZhang X; Zhang J; Yoshimoto M; Liu S; Bijian K; Gupta A; Squire JA; Alaoui Jamali MA; Bismar TA
    J Pathol; 2011 May; 224(1):90-100. PubMed ID: 21381033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint.
    Ju X; Casimiro MC; Gormley M; Meng H; Jiao X; Katiyar S; Crosariol M; Chen K; Wang M; Quong AA; Lisanti MP; Ertel A; Pestell RG
    Cancer Res; 2014 Jan; 74(2):508-19. PubMed ID: 24282282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer.
    Alioui A; Dufour J; Leoni V; Loregger A; Moeton M; Iuliano L; Zerbinati C; Septier A; Val P; Fouache A; Russo V; Volle DH; Lobaccaro JA; Zelcer N; Baron S
    Nat Commun; 2017 Sep; 8(1):445. PubMed ID: 28874658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic function of Smad4 and PTEN in suppressing forestomach squamous cell carcinoma in the mouse.
    Teng Y; Sun AN; Pan XC; Yang G; Yang LL; Wang MR; Yang X
    Cancer Res; 2006 Jul; 66(14):6972-81. PubMed ID: 16849541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP suppresses PTEN expression via RAS/ERK signaling.
    Beck SE; Carethers JM
    Cancer Biol Ther; 2007 Aug; 6(8):1313-7. PubMed ID: 18059158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors.
    Kwak MK; Johnson DT; Zhu C; Lee SH; Ye DW; Luong R; Sun Z
    PLoS One; 2013; 8(1):e53476. PubMed ID: 23308230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.
    Arvai KJ; Hsu YH; Lee LA; Jones D
    PLoS One; 2015; 10(6):e0131108. PubMed ID: 26098881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer induced by loss of Apc is restrained by TGFβ signaling.
    Bjerke GA; Pietrzak K; Melhuish TA; Frierson HF; Paschal BM; Wotton D
    PLoS One; 2014; 9(3):e92800. PubMed ID: 24651496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer.
    Zhao D; Cai L; Lu X; Liang X; Li J; Chen P; Ittmann M; Shang X; Jiang S; Li H; Meng C; Flores I; Song JH; Horner JW; Lan Z; Wu CJ; Li J; Chang Q; Chen KC; Wang G; Deng P; Spring DJ; Wang YA; DePinho RA
    Cancer Discov; 2020 Sep; 10(9):1374-1387. PubMed ID: 32385075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.